{"log_id": 3269151347056592128, "direction": 0, "words_result_num": 40, "words_result": [{"probability": {"variance": 0, "average": 0.993762, "min": 0.993762}, "location": {"width": 34, "top": 379, "height": 32, "left": 340}, "words": "胎"}, {"probability": {"variance": 0.009748, "average": 0.956192, "min": 0.528866}, "location": {"width": 864, "top": 416, "height": 59, "left": 406}, "words": "2.抗肿瘤治疗,联合使用:急性白血病(特别是急性淋巴细胞性白血病"}, {"probability": {"variance": 0.022296, "average": 0.905915, "min": 0.399507}, "location": {"width": 971, "top": 454, "height": 59, "left": 340}, "words": " Burkitts淋已,晚期淋巴肉瘤(I和IV期,据 Peter:分期法)和晚期萝每"}, {"probability": {"variance": 0.001032, "average": 0.967089, "min": 0.934958}, "location": {"width": 59, "top": 491, "height": 32, "left": 338}, "words": "菌病"}, {"probability": {"variance": 0.009429, "average": 0.957499, "min": 0.540768}, "location": {"width": 610, "top": 528, "height": 54, "left": 404}, "words": "3.鞘内注射:治疗脑膜转移癌(只能使用等渗制剂"}, {"probability": {"variance": 0.009483, "average": 0.944243, "min": 0.537968}, "location": {"width": 871, "top": 564, "height": 66, "left": 434}, "words": "大剂量治疗:大剂量甲氨螺呤单独应用成与其它化疗药物我合用治疗"}, {"probability": {"variance": 0.016468, "average": 0.942648, "min": 0.357109}, "location": {"width": 971, "top": 601, "height": 66, "left": 336}, "words": "下列肿:成骨肉瘤、急性白血病、支气管肺癌或头颈部表皮癌。大氨蝶"}, {"probability": {"variance": 0.013665, "average": 0.952957, "min": 0.421117}, "location": {"width": 976, "top": 637, "height": 70, "left": 329}, "words": "呤应时,必须应用亚叶酸进行解救。亚叶酸是四氢叶酸酯的衍生甲氨"}, {"probability": {"variance": 0.029543, "average": 0.892359, "min": 0.415866}, "location": {"width": 1095, "top": 669, "height": 89, "left": 329}, "words": "蝶呤竞争进入细胞内。这种“亚叶酸解救”可在大剂量甲氨蝶呤应用护常少"}, {"probability": {"variance": 3.2e-05, "average": 0.994649, "min": 0.980735}, "location": {"width": 224, "top": 720, "height": 36, "left": 331}, "words": "组织细胞免受损害"}, {"probability": {"variance": 0.009161, "average": 0.951662, "min": 0.521515}, "location": {"width": 839, "top": 759, "height": 61, "left": 400}, "words": "5.银屑化疗:甲氨蝶呤可用于治疗对常规疗法不敏感的严重、顽固"}, {"probability": {"variance": 0.003204, "average": 0.972434, "min": 0.750249}, "location": {"width": 971, "top": 793, "height": 66, "left": 326}, "words": "残性银屑病。但因使用时有较大危险,应在经过活检和/或皮肤科医生会诊明确"}, {"probability": {"variance": 1e-06, "average": 0.999207, "min": 0.998013}, "location": {"width": 141, "top": 834, "height": 34, "left": 326}, "words": "诊断后使用"}, {"probability": {"variance": 1.2e-05, "average": 0.994799, "min": 0.98993}, "location": {"width": 100, "top": 907, "height": 36, "left": 331}, "words": "【规格】"}, {"probability": {"variance": 0.030323, "average": 0.902507, "min": 0.555276}, "location": {"width": 77, "top": 951, "height": 32, "left": 427}, "words": "(1)2m"}, {"probability": {"variance": 0.016077, "average": 0.927955, "min": 0.523445}, "location": {"width": 429, "top": 953, "height": 52, "left": 624}, "words": "2)20m1:500mg;(3)10m2:1000mg"}, {"probability": {"variance": 1.6e-05, "average": 0.991697, "min": 0.984834}, "location": {"width": 155, "top": 1021, "height": 38, "left": 324}, "words": "【用法用量】"}, {"probability": {"variance": 0.015108, "average": 0.949285, "min": 0.449551}, "location": {"width": 706, "top": 1097, "height": 61, "left": 370}, "words": "抗肿瘤化疗:甲氨蝶吟可采用肌肉、静脉或内注射给药"}, {"probability": {"variance": 0.031847, "average": 0.849392, "min": 0.429568}, "location": {"width": 964, "top": 1134, "height": 70, "left": 388}, "words": "ml:10g规格的甲氨蝶呤注射液为高渗溶液,禁用于内注射1S18"}, {"probability": {"variance": 0.026668, "average": 0.913758, "min": 0.429195}, "location": {"width": 1019, "top": 1168, "height": 75, "left": 368}, "words": "当用于鞘内注射时,甲氨摸呤注射液应该用适当的不含防腐剂的中"}, {"probability": {"variance": 0.022808, "average": 0.913831, "min": 0.430569}, "location": {"width": 512, "top": 1209, "height": 54, "left": 306}, "words": "D.9%氯化钠注射液稀释至1mg/ml的度"}, {"probability": {"variance": 0.030024, "average": 0.899429, "min": 0.421801}, "location": {"width": 1051, "top": 1248, "height": 61, "left": 368}, "words": "对于转接mgkg体重至g体表面积或反之,指南推荐1:3的,根"}, {"probability": {"variance": 0.012249, "average": 0.949224, "min": 0.543386}, "location": {"width": 925, "top": 1282, "height": 86, "left": 308}, "words": "据年龄和体格的不同选择的转换系数范围在1:20与1:40之间"}, {"probability": {"variance": 0.013951, "average": 0.949103, "min": 0.404828}, "location": {"width": 909, "top": 1360, "height": 66, "left": 370}, "words": "毛膜癌及类似滋养细胞疾病:常规剂量是15-30mg/日,肌注5天通常"}, {"probability": {"variance": 0.013205, "average": 0.954593, "min": 0.476601}, "location": {"width": 944, "top": 1399, "height": 64, "left": 333}, "words": "至数周后,在所有毒性反应全部清失后,再开始下一个疗程。通常需要3-5个"}, {"probability": {"variance": 3.6e-05, "average": 0.99323, "min": 0.987191}, "location": {"width": 59, "top": 1438, "height": 29, "left": 304}, "words": "疗程"}, {"probability": {"variance": 0.01943, "average": 0.937929, "min": 0.385677}, "location": {"width": 903, "top": 1474, "height": 64, "left": 372}, "words": "治疗的疗效可采用24小时尿HCG(人毛膜促性腺激素)定量分析进行评"}, {"probability": {"variance": 0.019895, "average": 0.923519, "min": 0.419754}, "location": {"width": 973, "top": 1508, "height": 68, "left": 301}, "words": "估。在第三或第四疗程后,HCG水平应回到正常或低于50U/24h.可测量病灶通"}, {"probability": {"variance": 0.015081, "average": 0.933167, "min": 0.478297}, "location": {"width": 976, "top": 1547, "height": 68, "left": 299}, "words": "常在4-6周后可完全消除。HCG水平恢复正常后,建议继续给予1或2疗程"}, {"probability": {"variance": 0.000676, "average": 0.982976, "min": 0.9277}, "location": {"width": 198, "top": 1586, "height": 43, "left": 297}, "words": "甲氨蝶呤的治疗"}, {"probability": {"variance": 0.026613, "average": 0.928625, "min": 0.363919}, "location": {"width": 903, "top": 1625, "height": 64, "left": 368}, "words": "每个疗程开始前,必须进行详细的临床评估。甲氨蝶呤可与其抗肿药"}, {"probability": {"variance": 2e-06, "average": 0.998738, "min": 0.995822}, "location": {"width": 144, "top": 1664, "height": 34, "left": 294}, "words": "物联合使用"}, {"probability": {"variance": 0, "average": 0.92486, "min": 0.92486}, "location": {"width": 34, "top": 1717, "height": 27, "left": 1259}, "words": "a"}, {"probability": {"variance": 0.011983, "average": 0.962787, "min": 0.42484}, "location": {"width": 919, "top": 1737, "height": 66, "left": 347}, "words": "乳腺癌:对于淋巴结阳性的早期乳腺癌患者,作为乳腺癌根治后的辅助治"}, {"probability": {"variance": 0.01872, "average": 0.943275, "min": 0.438972}, "location": {"width": 960, "top": 1776, "height": 66, "left": 285}, "words": "疗,甲氨蝶吟联合环酰胺、氟尿嘧啶进行长期周期性化疗可取得较好的疗效"}, {"probability": {"variance": 0.009054, "average": 0.958292, "min": 0.531072}, "location": {"width": 695, "top": 1815, "height": 59, "left": 288}, "words": "甲氨蝶呤的剂量为40mg/m2,于第一天和第八天静脉给药"}, {"probability": {"variance": 0.000461, "average": 0.986382, "min": 0.911935}, "location": {"width": 930, "top": 1895, "height": 64, "left": 333}, "words": "白血病:儿童和青少年急性淋巴细胞性(淋巴母细胞性)白血病患者对目前"}, {"probability": {"variance": 0.001458, "average": 0.984672, "min": 0.835574}, "location": {"width": 978, "top": 1931, "height": 66, "left": 281}, "words": "的化疗反应性最强。青年和老年患者更难获得临床缓解,早期复发比较常见。在"}, {"probability": {"variance": 0.009874, "average": 0.9702, "min": 0.411687}, "location": {"width": 980, "top": 1970, "height": 64, "left": 281}, "words": "慢性淋巴细胞性白血病中,化疗敏感性不佳。甲氨蝶单用或与类固醇联用最初"}, {"probability": {"variance": 0.002056, "average": 0.968471, "min": 0.889509}, "location": {"width": 164, "top": 2041, "height": 32, "left": 690}, "words": "第2页,共15页"}], "language": 3}